Product Description: Pegaldesleukin is a conjugate of polyethylene glycol and interleukin-2 (PEG-IL2). Pegaldeslukin has antiviral activity and has potential applications in HIV, possibly delaying the progression of HIV infection by retaining the immune repertoire[1][2][3].
Applications: COVID-19-anti-virus
Formula: N/A
References: [1]Vet—QL03AC01 A T C. Interleukin-2[J]. Lancet, 1992, 339: 1061./[2]Sharma G, et al. Compositions and methods for treating viral infections. United States. US20100081713./[3]Carr A. Interleukin-2 may delay HIV progression[J]. Inpharma, 1998, 1165: 28.
CAS Number: 141752-91-2
Molecular Weight: N/A
Research Area: Infection
Solubility: 10 mM in DMSO
Target: HIV;Interleukin Related